Sutton Wealth Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
PCMI
Sutton Wealth Advisors's ANGO Position: Q1 2023 in Review
Sutton Wealth Advisors sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 634 shares — an estimated $8.73K sold.
Sutton Wealth Advisors first reported a position in ANGO in Q1 2018 and held it in 19 quarters. The position peaked at $12.8K in Q4 2021. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.
- Sutton Wealth Advisors reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
- Sutton Wealth Advisors sold 634 AngioDynamics shares in Q1 2023, an estimated $8.73K.
- Sutton Wealth Advisors first reported a position in AngioDynamics in Q1 2018 and held it in 19 quarters.
- Sutton Wealth Advisors's AngioDynamics position peaked at $12.8K in Q4 2021.
- 153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.
Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.